611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
How Folks Are Coping With Post-COVID Loss of Smell, TasteRoutine Ventilation of Surgical Patients Won't Raise COVID Transmission RiskImmunocompromised May Need Fourth COVID Shot: CDCLiver Transplants Soar as Some Americans Drink Their Way Through the PandemicFDA Advisors Approve Emergency Use of Pfizer COVID Vaccine in Kids 5 to 11COVID Vaccination Can Be Safe Even in People With Severe AllergiesTargeted High-Dose Radiation Helps Fight Advanced Lung CancerTrader Joe's Salami Snacks Tied to 20 Salmonella Cases in 8 StatesWhite House Takes More Steps to Boost Supply of Rapid at-Home COVID TestsBiden Administration Announces Details of Vaccination Requirements for Foreign TravelersAHA News: Never Heard of Sepsis? It's Common, Dangerous and a Threat to Your HeartModerna Says Its COVID Vaccine Works Well in Children Aged 6 to 11COVID Vaccination Does Not Raise Odds of Miscarriage: StudyVaccinated People Less Likely to Die of Any Cause in Months After Shots: CDCRecovering COVID Patients Often Face Long-Term 'Brain Fog'COVID Pandemic May Have Driven a Flu Strain Into ExtinctionThe No. 1 Cause of Halloween Injuries: Carving the PumpkinPfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDAPfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenDeadly Liver Disease Tied to Obesity Is on the RiseCDC Signs Off on Moderna, J&J Boosters, Backs Mix n' Match ShotsMoving Monoclonal Antibody Treatments for COVID From Hospital to HomeConfusion, Seizures: People Hospitalized After Taking Veterinary Drug for COVIDMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyPfizer Vaccine Booster Restores Nearly Full Protection, Company SaysTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseSex of Fetus May Matter When COVID Strikes in PregnancyVaccines Cut Odds for Death From COVID Delta Variant by 90%U.S. Has Shared 200 Million Shots With Other CountriesSalmonella Outbreak in 37 States Linked to Imported OnionsFDA Approves Moderna, J&J Booster Shots, Backs Mix n' Match VaccinesWhite House Announces COVID Vaccination Plan for Young KidsEven With Mild COVID, Obesity May Mean Worse SymptomsNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsFlu Cases Already Up 23% This Season: WalgreensDoctors Report That Kidney Grown in Pig Worked in a HumanHeartburn Meds Might Be Good for Your GumsOne Big Factor for Survival After Spinal Cord Injury: ResilienceDying Young From Heart Disease: Where You Live in the U.S. MattersFDA Expected to Allow Mix n' Match COVID VaccinesPowell's COVID Death Despite Vaccination Shows Danger to Those With Weakened Immune SystemsAHA News: Your Next Doctor's Prescription Might Be to Spend Time in NatureOut-of-Pocket Medical Bills for COVID-19 May Average $3,800 in 2021: StudyLegionnaires' Disease Outbreak Hits Long Island, N.Y.State Lotteries Didn't Help Boost Vaccination RatesFDA Panel Recommends Approval of Johnson & Johnson Booster ShotHeart Defibs in Schools Are Saving Staff Lives: StudyHorseback Riding Carries Big Risk for Serious Injury: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: Poll
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Existing Drugs Could Treat Lung Cancer in Nonsmokers

HealthDay News
by Steven Reinberg
Updated: Oct 4th 2021

new article illustration

MONDAY, Oct. 4, 2021 (HealthDay News) -- There's some encouraging news for people who develop lung cancer even though they've never smoked.

Precision drugs already approved by the U.S. Food and Drug Administration can be used to treat 78% to 92% of their tumors, a new study reports. These precision drugs target specific mutations in tumors.

Most never-smokers' lung tumors have so-called driver mutations, specific mistakes in DNA that fuel tumor growth. A variety of drugs can block these mutations. Among smokers, only about half of lung cancers have these mutations, according to researchers.

Study author Dr. Ramaswamy Govindan said most lung cancer studies have focused on smokers, and even those that investigated the disease in people who have never used tobacco have not looked for "specific, actionable mutations" in a systematic way. An accurate tissue study is essential, he said.

"The patient must have a high-quality biopsy to make sure there is enough genetic material to identify key mutations," said Govindan, a professor of medicine at Washington University School of Medicine in St. Louis. "But testing these patients is critical. There is a high chance such patients will have an actionable mutation that we can go after with specific therapies."

His team analyzed lung tumors from 160 patients with lung cancer and no history of smoking. Researchers also compared data from these patients with data from smokers and never-smokers compiled by a pair of U.S. National Institutes of Health programs that characterized different types of cancer.

"Tobacco smoking leads to characteristic changes in the tumor cells, so we can look for telltale signs of smoking or signs of heavy exposure to secondhand smoke, for example," Govindan said in a university news release. "But very few of these patients' tumors showed those signs, so we could verify that this was truly a sample of lung cancer tumors in patients who had never smoked or had major exposure to tobacco smoke."

About 7% of these patients had evidence of mutations at birth that raised the risk of cancer -- either inherited or arising randomly, adding to the mystery of what causes lung cancer in people who have never used tobacco, the study found.

"There appears to be something unique about lung cancer in people who have never smoked," Govindan said. "We didn't find a major role for inherited mutations, and we don't see evidence of large numbers of mutations, which would suggest exposure to secondhand smoke."

He noted that about 60% of these tumors are found in females and 40% in males. While cancer in general is more common among men, lung cancer in people who never smoked is more common among women, for some unexplained reasons.

"The most important finding is that we identified actionable mutations in the vast majority of these patients -- between 80% and 90%," Govindan said. "Our study highlights the need to obtain high-quality tumor biopsies for clinical genomic testing in these patients, so we can identify the best targeted therapies for their individual tumors."

The findings were published Sept. 30 in the Journal of Clinical Oncology.

More information

For more about lung cancer and treatments, visit the American Cancer Society.


SOURCE: Washington University School of Medicine in St. Louis, news release, Sept. 30, 2021